Why India has the largest Hydroxychloroquine(HCQ)?
•India manufactures 70% of the world’s supply of hydroxychloroquine, according to Indian Pharmaceutical Alliance (IPA)
•The drug is not manufactured in developed nations such as the US because of non-existent malaria.
•India currently has an annual installed capacity of around 40 metric tonnes of active pharmaceutical ingredients (APIs) of hydroxychloroquine.
[ With this capacity, “we can make around 200 million tablets of 200 mg”]
•Recently, the Ministry of Health and Family Welfare had reportedly placed an order for around 10 crore tables of HCQ with Ipca laboratories and Zydus Cadila
•Hydroxy-chloroquine is an oral drug used in the treatment of malaria and some autoimmune diseases such as rheumatoid arthritis
•Recent studies show that the HCQ drug alone or in combination with azithromycin appears to reduce the virus quickly.
[Further, the study suggests that prophylaxis (treatment given to prevent disease) with hydroxy-chloroquine at approved doses could prevent SARS-CoV-2 infection.]
▪️The ban on HCQ was revoked by India after U.S. President said that India could invite “retaliation” if it withheld supplies of HCQ
International Criminal Police Organisation (Interpol)
•It is an intergovernmental organization that helps coordinate the police force of 194 member countries [ HQ:- Lyon, France]
•Each of the member countries hosts an interpol National Central Bureau (NCB). [Central Bureau of Investigation (CBI) is designated as the National Central Bureau of India.]
• Recently, Interpol has warned member countries that cybercriminals are attempting to target major hospitals and other institutions on the front lines of the fight against COVID-19 with ransomware
•In an alert sent to 194 nations, including India, Interpol said that the hospitals and institutions had become targets of ransomware attacks.
Global Initiative on Sharing All Influenza Data(GISAID)
•It is a public platform started by the World Health Organization (WHO) in 2008 for countries to share genome sequences.
•GISAID Initiative promotes the international sharing of all influenza virus sequences, related clinical and epidemiological data associated with human viruses, and geographical as well as species-specific data associated with avian and other animal viruses
•India has shared nine whole genome sequences of the novel coronavirus (SARS-CoV-2) with the Global Initiative on Sharing All Influenza Data (GISAID)
•So far, 3,086 sequences of the virus isolated from humans have been shared by 57 countries.
[With 621, the U.S. has shared the most number of sequences, followed by the U.K. (350), Belgium (253) and China (242)]
China became the biggest source of applications for international patents
•China has pushed the United States from the top position which it has held since the global system was set up more than 40 years ago
•China filed 58,990 applications beating the 57,840 applications filed by the U.S
•China’s success can be attributed to the deliberate strategy of advancing innovations and to make the country’s economy operate at a higher level of value.
•In the current times, more than half of patent applications, almost 52.4%, come from Asia.
[India was placed at 36th position among 50 countries in 2019]
•Japan is on the third rank followed by Germany and South Korea
▪️Recently, the World Intellectual Property Organization (WIPO) has highlighted that China has become the biggest source of applications for international patents in the world
•Recently, a mega online challenge, SAMADHAN has been launched to test the ability of students to innovate
•Under the challenge, the participating students will search and develop measures against Coronavirus
•The challenge will inspire students and faculty for novel experiments and discoveries providing a strong baseline of experimentation
▪️The Innovation Cell of the Ministry of Human Resources Development and All India Council for Technical Education (AICTE) has launched it in collaboration with Forge and InnovatioCuris (an organisation on healthcare expertise)